Skip to main content

AQR CAPITAL MANAGEMENT LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1167557 Greenwich, CT

Position in DSGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$276,179
+$147,395 QoQ
Shares Held
25,957
+89.1% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,607,351,941 across 214 Biotechnology names. DSGN ranks #184 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $276,179 25,957
2025-12-31 $128,784 13,730
2025-09-30 $102,887 13,664
2025-06-30 $96,804 28,726
2025-03-31 $122,514 31,740
2024-12-31 $184,204 29,855
2024-09-30 $58,016 10,784
2024-06-30 $37,127 11,083
2024-03-31 $47,343 11,748
2023-12-31 $149,036 56,240